Vaccination programs save millions of lives every year across the world. With more than 100 million children are immunized each year; global immunization coverage has never been higher. Sources indicate that the global market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. Industry experts observe that roadblocks still prevail, especially to vaccine manufacturers from developing and emerging markets such as: Regulatory challenges along the vaccine development value chain, challenges in performing and designing clinical trials for novel vaccines, scale-up, manufacturing productivity and costreduction in downstream processing, thermostable vaccine development and so forth. This event promises to be an opportunity to meet the vaccine companies from developed as well as developing
countries, industry leaders, regulatory officials, academia and network with vaccine players worldwide.
Here you can read more about Viroclinics Biosciences’ contribution to the 9th Annual World Vaccine Summit 2019.